Quantcast

Esperite starts developing inflammatory bowel disease therapies; Starts with Crohn`s disease

Esperite`s business unit The Cell Factory in collaboration with Women`s and Children`s Health Department of the University of Padua and the Padua University Hospital are developing therapies for inflammatory bowel disease (IBD) using extracellular vesicles (EVs).

Read more